HCA Healthcare, Inc. HCA SPX
Healthcare · Medical Care Facilities · United States
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
READ MORE ›$378.54
-0.08% 1Y
Market & Price
Market Cap
$83.98B
Current Price
$378.54
High / Low (52W)
$544.32 / $332.73
Beta
1.19
Valuation
Stock P/E
13.04
Industry PE
23.65
Forward P/E
11.42
PEG Ratio
1.14
Book Value
$-28.32
Price to Book
-13.36
P/S
1.10
EV/EBITDA
8.74
Dividend Yield
0.82%
Profitability & Returns
ROCE
27.23%
ROE
-
ROA
12.34%
Profit Margin
8.89%
Op Margin
14.98%
EPS (Latest Qtr)
$7.15
EPS (TTM)
$29.03
Balance Sheet & Liquidity
Debt/Equity
-
Quick Ratio
0.64
Current Ratio
0.83
Debt
$49.84B
Total Assets
$60.72B
Current Assets
$15.78B
Working Capital
$-567.00M
Ownership
Promoter Holding
16.28%
Chg in Prom Hold
-
FII / Inst Holding
78.28%
Chg in FII Hold
0.01%
Financial Snapshot
Enterprise Value
$136.08B
Total Revenue (TTM)
$76.39B
EBITDA
$15.57B
Free Cash Flow
$5.73B
Operating Cash Flow
$13.00B
Shares Outstanding
221.84M
Gross Margin
41.61%
Payout Ratio
10.13%
Growth (CAGR)
Revenue 5Y
7.87%
Profit 5Y
6.33%
Revenue (YoY)
4.30%
Earnings (YoY)
10.90%
PROS
- Healthy ROCE of 27.2%.
- Generates positive free cash flow.
CONS
- Trading 30.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
- RSI at 20 suggests oversold conditions.
* The pros and cons are auto-generated from financial metrics.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth
No fundamental data available for this stock.
Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HCA HCA Healthcare, Inc. SPX | 378.54 | 13.04 | $83.98B | 0.82% | 27.23% | - | 7.87% | 6.33% |
| 2 | LLY Eli Lilly and Company SPX | 1,105.00 | 39.21 | $985.37B | 0.63% | 38.44% | 107.46% | 31.69% | 48.96% |
| 3 | JNJ Johnson & Johnson SPX | 225.33 | 26.11 | $542.42B | 2.38% | 23.13% | 26.42% | 5.60% | 14.32% |
| 4 | UNH UnitedHealth Group Incorporated SPX | 380.31 | 28.66 | $345.38B | 2.32% | 9.60% | 12.18% | 11.35% | -15.69% |
| 5 | MRK Merck & Co., Inc. SPX | 118.72 | 33.44 | $293.22B | 2.86% | 20.66% | 18.94% | 3.12% | 7.93% |
| 6 | TMO Thermo Fisher Scientific Inc. SPX | 492.51 | 27.11 | $183.03B | 0.38% | 9.17% | 13.52% | -0.27% | -1.19% |
| 7 | AMGN Amgen Inc. NDXSPX | 336.79 | 23.42 | $181.77B | 2.99% | 18.02% | 101.32% | 11.77% | 5.58% |
| 8 | GILD Gilead Sciences, Inc. NDXSPX | 134.43 | 18.29 | $166.90B | 2.44% | 22.92% | 43.36% | 2.57% | 22.83% |
| 9 | ISRG Intuitive Surgical, Inc. NDXSPXAI | 424.64 | 51.53 | $150.39B | - | 15.96% | 17.23% | 17.39% | 29.26% |
Ad space
Quarterly Results
Figures in USD.
| Metric | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.98B | 14.44B | 15.28B | 14.95B | 14.82B | 14.97B | 15.59B | 15.86B | 16.21B | 17.34B | 17.49B | - | - | 18.32B | 18.61B | 19.16B | 19.51B | 19.11B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.76B | 10.98B | 11.15B | 11.34B | 11.14B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 7.56B | 7.62B | 8.02B | 8.18B | 7.97B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.71B | 4.66B | 5.05B | 5.00B | 5.11B |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.85B | 2.97B | 2.96B | 3.18B | 2.86B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.73B | 3.85B | 3.87B | 4.16B | 3.80B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 547.00M | 568.00M | 561.00M | 572.00M | 584.00M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.33B | 2.42B | 2.42B | 2.67B | 2.29B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 502.00M | 524.00M | 515.00M | 509.00M | 430.00M |
| Net Income | 507.00M | 449.00M | 582.00M | 694.00M | 658.00M | 618.00M | 920.00M | 659.00M | 657.00M | 426.00M | 474.00M | 1.14B | 820.00M | 759.00M | 1.06B | 1.04B | 783.00M | 612.00M | 1.07B | 581.00M | 1.08B | 668.00M | 1.42B | 1.45B | 2.27B | 1.27B | 1.16B | 1.13B | 1.36B | 1.19B | 1.08B | 1.59B | 1.46B | - | - | 1.61B | 1.65B | 1.64B | 1.88B | 1.62B |
| Diluted EPS | 1.18 | 1.05 | 1.40 | 1.69 | 1.65 | 1.59 | 2.39 | 1.74 | 1.75 | 1.15 | 1.30 | 3.18 | 2.31 | 2.15 | 3.01 | 2.97 | 2.25 | 1.76 | 3.09 | 1.69 | 3.16 | 1.95 | 4.14 | 4.36 | 7.00 | 4.14 | 3.90 | 3.91 | 4.85 | 4.29 | 3.91 | 5.93 | 5.53 | - | - | 6.45 | 6.83 | 6.96 | 8.14 | 7.15 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | 51.34B | 51.53B | - | 60.23B | 64.97B | 70.60B | 75.60B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | 37.06B | 39.39B | 41.92B | 44.23B |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | 23.18B | 25.58B | 28.68B | 31.37B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.12B | 15.95B | 18.13B | 19.41B |
| Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.05B | 9.63B | 10.55B | 11.96B |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.29B | 12.72B | 13.90B | 15.60B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.74B | 1.94B | 2.06B | 2.25B |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.58B | 7.71B | 8.52B | 9.83B |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.75B | 1.61B | 1.87B | 2.05B |
| Net Income | 1.05B | 1.21B | 2.46B | 1.60B | 1.56B | 1.88B | 2.13B | 2.89B | 2.22B | 3.79B | 3.50B | 3.75B | - | 5.64B | 5.24B | 5.76B | 6.78B |
| Diluted EPS | 2.44 | 2.76 | 4.97 | 3.49 | 3.37 | 4.16 | 4.99 | 7.30 | 5.95 | 10.66 | 10.07 | 10.93 | - | 19.15 | 18.97 | 22.00 | 28.33 |
Compounded Sales Growth
| 5 Years: | 7.87% |
| 1 Year: | 4.30% |
Compounded Profit Growth
| 5 Years: | 6.33% |
| 1 Year: | 10.90% |
Stock Price Performance
| 1 Year: | -0.08% |
| 6 Months: | -26.40% |
| 3 Months: | -28.43% |
| 1 Month: | -12.94% |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 23.85B | 26.90B | 28.07B | 28.59B | 30.98B | 32.74B | 33.76B | 36.59B | 39.21B | 45.06B | 47.49B | - | 52.44B | 56.21B | 59.51B | 60.72B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.64B | 14.93B | 16.41B | 15.78B |
| Cash & Equivalents | 465.00M | 312.00M | 411.00M | 373.00M | 705.00M | 414.00M | 566.00M | 741.00M | 646.00M | 732.00M | 502.00M | 621.00M | 1.79B | - | 908.00M | 935.00M | 1.93B | 1.04B |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.07B | 2.02B | 1.74B | 1.65B |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.89B | 9.96B | 10.75B | 10.87B |
| Total Liabilities | - | - | - | 33.91B | 36.42B | 35.76B | 37.48B | 38.79B | 39.39B | 41.59B | 42.12B | 45.62B | - | - | 52.51B | 55.15B | 58.96B | 63.49B |
| Current Liabilities | - | - | 4.27B | 5.55B | 6.17B | 5.70B | 5.48B | 5.52B | 5.83B | 6.16B | 7.57B | 7.76B | 8.70B | - | 9.90B | 12.65B | 15.18B | 16.35B |
| Long Term Debt | - | - | 27.63B | 25.64B | 27.50B | 27.59B | 29.09B | 30.25B | 31.16B | 32.86B | 32.03B | 33.58B | 30.80B | - | 37.71B | 37.17B | 38.33B | 41.60B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40.20B | 41.86B | 45.24B | 48.70B |
| Total Equity | - | - | 11.93B | -8.26B | -9.66B | -8.27B | -7.89B | -7.60B | -7.30B | -6.81B | -4.95B | -2.81B | 572.00M | - | -2.77B | -1.77B | -2.50B | -6.03B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 277.38M | 265.54M | 249.98M | 224.61M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.75B | 3.08B | 3.93B | 4.17B | 3.68B | 4.45B | - | 5.65B | 5.43B | 6.76B | 7.60B | 9.23B | 8.96B | 8.52B | 9.43B | 10.51B | 12.64B |
| Investing Cash Flow | -1.03B | -1.04B | -3.00B | -2.06B | -2.35B | -2.92B | - | -3.24B | -4.28B | -3.90B | -5.72B | -3.39B | -2.64B | -3.39B | -5.32B | -4.93B | -4.99B |
| Financing Cash Flow | -1.86B | -1.95B | -976.00M | -1.78B | -1.62B | -1.38B | - | -2.51B | -1.06B | -3.08B | -1.77B | -4.68B | -6.66B | -5.66B | -4.09B | -4.58B | -8.55B |
| Capital Expenditure | -1.32B | -1.32B | -1.68B | -1.86B | -1.94B | -2.18B | -2.38B | -2.76B | -3.02B | -3.57B | -4.16B | -2.83B | -3.58B | -4.39B | -4.74B | -4.88B | -4.94B |
| Free Cash Flow | 1.43B | 1.76B | 2.25B | 2.31B | 1.74B | 2.27B | - | 2.89B | 2.41B | 3.19B | 3.44B | 6.40B | 5.38B | 4.13B | 4.69B | 5.64B | 7.69B |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | -523.00M | 20.00M | 999.00M | -902.00M |
| Share Buybacks | - | - | 1.50B | - | 500.00M | 1.75B | 2.40B | 2.75B | 2.05B | 1.53B | 1.03B | 441.00M | 8.21B | 7.00B | 3.81B | 6.04B | 10.07B |
| Dividends Paid | - | - | - | - | - | - | - | - | 0 | 487.00M | 550.00M | 153.00M | 624.00M | 653.00M | 661.00M | 690.00M | 679.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 38.5% | 39.4% | 40.6% | 41.5% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.0% | 14.8% | 14.9% | 15.8% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | 6.8% | 7.3% | - | 9.4% | 8.1% | 8.2% | 9.0% |
| ROE % | - | 10.1% | -29.8% | -16.6% | -18.8% | -23.8% | -28.0% | -39.6% | -32.6% | -76.5% | -124.8% | 656.3% | - | -203.9% | -295.5% | -230.5% | -112.6% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | 21.3% | 22.1% | 23.8% | 27.0% |
Shareholding Pattern
Insiders
16.28%
Institutions
78.28%
Public Float
93.51%
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Blackrock Inc. | 6.02% | 13.36M | $5.06B |
| 2 | Vanguard Capital Management LLC | 4.59% | 10.18M | $3.85B |
| 3 | Sanders Capital, LLC | 4.04% | 8.96M | $3.39B |
| 4 | State Street Corporation | 3.40% | 7.54M | $2.85B |
| 5 | FMR, LLC | 1.98% | 4.40M | $1.67B |
| 6 | Wellington Management Group, LLP | 1.76% | 3.91M | $1.48B |
| 7 | Geode Capital Management, LLC | 1.66% | 3.69M | $1.40B |
| 8 | First Eagle Investment Management, LLC | 1.47% | 3.25M | $1.23B |
| 9 | Capital International Investors | 1.37% | 3.03M | $1.15B |
| 10 | Vanguard Portfolio Management LLC | 1.24% | 2.76M | $1.04B |
Analyst View
Loading analyst coverage…
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HCA
No recent headlines available.